A new drug target to treat depression and other mood disorders may lie in a group of GABA neurons (gamma-aminobutyric acid - the neurotransmitters which inhibit other cells) shown to contribute to symptoms like social withdrawal and increased anxiety, Penn Medicine researchers report in a new study in the Journal of Neuroscience...